Bernhard Hoffmann
SVP of Corp. Dev. at Opus Genetics, Inc. (IRD)
Bernhard Hoffmann has filed 6 insider reports with the SEC since February 2022, as SVP of Corp. Dev. at Opus Genetics, Inc. (IRD). The latest filing, on March 18, 2025, reports grant or award at Opus Genetics, Inc. (IRD).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Bernhard Hoffmann is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| SVP of Corp. Dev. | 185,446 | $4.08 | Mar 18, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 13, 2025IRDSVP of Corp. Dev. Hoffmann Bernhard was granted 29,500 shares, increasing direct ownership by 19% to 185,446 unitsForm 4Grant or award
- Feb 4, 2025IRDSVP of Corp. Dev. Hoffmann Bernhard covered exercise/tax liability with 6,751 shares, decreasing direct ownership by 4% to 155,946 unitsForm 4Shares withheld for taxes or exercise price
- Jan 18, 2024IRDHoffmann Bernhard was granted 20,000 shares, increasing direct ownership by 14% to 162,697 unitsForm 4Grant or award
- Jan 10, 2024IRDHoffmann Bernhard covered exercise/tax liability with 4,031 shares, decreasing direct ownership by 3% to 142,697 unitsForm 4Shares withheld for taxes or exercise price
- Jan 10, 2023IRDSEC Form 4: Hoffmann Bernhard was granted 46,608 shares, increasing direct ownership by 47% to 146,728 unitsForm 4Grant or award
- Jan 28, 2022IRDSEC Form 4 filed by Hoffmann BernhardForm 4Grant or award
Compare Bernhard Hoffmann with
- Bernhard Hoffmann vs George Magrath1 shared
- Bernhard Hoffmann vs Robert E. Gagnon1 shared
- Bernhard Hoffmann vs Cam Gallagher1 shared
- Bernhard Hoffmann vs Benjamin R Yerxa1 shared
- Bernhard Hoffmann vs Joseph K Schachle1 shared
- Bernhard Hoffmann vs Rabourn Amy Zaremba1 shared
Other insiders at the same companies
- George MagrathIRD
- Foundation Fighting Blindness Retinal Degeneration FundIRD
- Cam GallagherIRD
- Robert E. GagnonIRD
- Benjamin R YerxaIRD
- Joseph K SchachleIRD
- Rabourn Amy ZarembaIRD
- Ashwath JayagopalIRD
- Richard J RodgersIRD
- Manuso James S JIRD
- Susan BentonIRD
- Adrienne L GravesIRD
- Jean BennettIRD
- Sean AinsworthIRD
- Nirav S. JhaveriIRD
Questions about Bernhard Hoffmann
- What is Bernhard Hoffmann's role at Opus Genetics, Inc.?
- Bernhard Hoffmann reports to the SEC as SVP of Corp. Dev. at Opus Genetics, Inc. (IRD), according to the latest filing on March 18, 2025.
- How many shares does Bernhard Hoffmann own?
- After the latest filing that states it, Bernhard Hoffmann directly owned 185,446 shares of Opus Genetics, Inc. (IRD). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Bernhard Hoffmann bought or sold stock recently?
- No open-market purchases or sales by Bernhard Hoffmann are on file. The filings report grant or award and shares withheld for taxes or exercise price.
- How do I get alerts when Bernhard Hoffmann files?
- Follow Bernhard Hoffmann on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Bernhard Hoffmann (SEC CIK 0001830354). Totals count each trade once, skipping amendments whose original is on file, from Feb 1, 2022 on. View on SEC EDGAR · Get this as JSON